Company intelligence / Profile preview

Bio Cape Grup

Cape Town, Western Cape, South Africa

Ownership: Private
Employees: ~8
Development stage: Other

Overview

Cape Bio Pharms manufactures high-quality, plant-made recombinant proteins (antibodies, peptides, fusion proteins, enzymes) using a plant-based expression platform for research applications. There are no clinical results as the company is not a therapeutic drug developer.

Therapeutic areas: Other
Modalities: ProteinPeptidesAntibodyFusion proteinEnzyme
Industry: Non-Drug Biotech

Partnerships

University of Cape Town (academic origin)

Beyond the preview

Go deeper on Bio Cape Grup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio Cape Grup.

Explore the full profile